• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ABCG2 不能催化谷胱甘肽外排,也不导致 GSH 依赖性的交叉耐药性。

ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivity.

机构信息

Drug Resistance Mechanism and Modulation Group, Ligue 2013 Certified, Bases Moléculaires et Structurales des Systèmes Infectieux, UMR5086, Centre National de la Recherche Scientifique, Université de Lyon, Institut de Biologie et Chimie des Protéines, University of Lyon Lyon, France.

出版信息

Front Pharmacol. 2013 Nov 7;4:138. doi: 10.3389/fphar.2013.00138. eCollection 2013.

DOI:10.3389/fphar.2013.00138
PMID:24312054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3819521/
Abstract

ABCG2 is a key human ATP-binding cassette (ABC) transporter mediating cancer cell chemoresistance. In the case of ABCC1, another multidrug transporter, earlier findings documented that certain modulators greatly increase ABCC1-mediated glutathione (GSH) efflux and, upon depletion of intracellular GSH, induce "collateral sensitivity" leading to the apoptosis of multidrug resistant cells. Recently, it has been suggested that ABCG2 may mediate an active GSH transport. In order to explore if ABCG2-overexpressing cells may be similarly targeted, we first looked for the effects of ABCG2 expression on cellular GSH levels, and for an ABCG2-dependent GSH transport in HEK293 and MCF7 cells. We found that, while ABCG2 overexpression altered intracellular GSH levels in these transfected or drug-selected cells, ABCG2 inhibitors or transport modulators did not influence GSH efflux. We then performed direct measurements of drug-stimulated ATPase activity and (3)H-GSH transport in inside-out membrane vesicles of human ABC transporter-overexpressing Sf9 insect cells. Our results indicate that ABCG2-ATPase is not modulated by GSH and, in contrast to ABCC1, ABCG2 does not catalyze any significant GSH transport. Our data suggest no direct interaction between the ABCG2 transporter and GSH, although a long-term modulation of cellular GSH by ABCG2 cannot be excluded.

摘要

ABCG2 是一种关键的人类三磷酸腺苷结合盒(ABC)转运蛋白,介导癌细胞的化疗耐药性。对于另一种多药转运蛋白 ABCC1,早期的研究结果表明,某些调节剂可显著增加 ABCC1 介导的谷胱甘肽(GSH)外排,当细胞内 GSH 耗尽时,会诱导“代偿性敏感性”,导致多药耐药细胞凋亡。最近,有人提出 ABCG2 可能介导活性 GSH 转运。为了探讨 ABCG2 过表达的细胞是否也可以被靶向,我们首先研究了 ABCG2 表达对细胞内 GSH 水平的影响,以及在 HEK293 和 MCF7 细胞中是否存在 ABCG2 依赖性的 GSH 转运。我们发现,虽然 ABCG2 过表达改变了这些转染或药物选择的细胞内 GSH 水平,但 ABCG2 抑制剂或转运调节剂并不影响 GSH 外排。然后,我们在人 ABC 转运蛋白过表达的 Sf9 昆虫细胞的外翻膜囊泡中进行了药物刺激的 ATP 酶活性和(3)H-GSH 转运的直接测量。我们的结果表明,GSH 不调节 ABCG2-ATP 酶,并且与 ABCC1 相反,ABCG2 不催化任何显著的 GSH 转运。我们的数据表明,ABCG2 转运体与 GSH 之间没有直接相互作用,尽管不能排除 ABCG2 对细胞内 GSH 的长期调节作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32b/3819521/6f630ccce74b/fphar-04-00138-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32b/3819521/b0888e40b58d/fphar-04-00138-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32b/3819521/89af1a110a6c/fphar-04-00138-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32b/3819521/af3006ad7e13/fphar-04-00138-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32b/3819521/105bac1d8d9f/fphar-04-00138-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32b/3819521/0ebcad0da6e9/fphar-04-00138-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32b/3819521/d4808f0de5da/fphar-04-00138-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32b/3819521/6f630ccce74b/fphar-04-00138-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32b/3819521/b0888e40b58d/fphar-04-00138-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32b/3819521/89af1a110a6c/fphar-04-00138-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32b/3819521/af3006ad7e13/fphar-04-00138-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32b/3819521/105bac1d8d9f/fphar-04-00138-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32b/3819521/0ebcad0da6e9/fphar-04-00138-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32b/3819521/d4808f0de5da/fphar-04-00138-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32b/3819521/6f630ccce74b/fphar-04-00138-g007.jpg

相似文献

1
ABCG2 is not able to catalyze glutathione efflux and does not contribute to GSH-dependent collateral sensitivity.ABCG2 不能催化谷胱甘肽外排,也不导致 GSH 依赖性的交叉耐药性。
Front Pharmacol. 2013 Nov 7;4:138. doi: 10.3389/fphar.2013.00138. eCollection 2013.
2
Jadomycins are cytotoxic to ABCB1-, ABCC1-, and ABCG2-overexpressing MCF7 breast cancer cells.Jadomycins 对 ABCB1、ABCC1 和 ABCG2 过表达的 MCF7 乳腺癌细胞具有细胞毒性。
Anticancer Drugs. 2014 Mar;25(3):255-69. doi: 10.1097/CAD.0000000000000043.
3
Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro.细胞周期蛋白依赖性激酶抑制剂AT-7519、黄酮哌啶醇和SNS-032与ABCB1、ABCG2和ABCC1转运蛋白的相互作用及其在体外克服多药耐药性的潜力。
Cancer Chemother Pharmacol. 2015 Jul;76(1):105-16. doi: 10.1007/s00280-015-2772-1. Epub 2015 May 19.
4
Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro.地那西布,一种细胞周期蛋白依赖性激酶抑制剂,是人体 ABCB1 和 ABCG2 的底物,也是体外人体 ABCC1 的抑制剂。
Biochem Pharmacol. 2015 Dec 1;98(3):465-72. doi: 10.1016/j.bcp.2015.08.099. Epub 2015 Aug 20.
5
Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.达可替尼通过抑制 ABCB1 和 ABCG2 转运蛋白的外排活性来拮抗癌细胞中的多药耐药(MDR)。
Cancer Lett. 2018 May 1;421:186-198. doi: 10.1016/j.canlet.2018.01.021. Epub 2018 Jan 11.
6
Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.姜黄素的主要代谢产物四氢姜黄素对三种ABC药物转运蛋白,即P-糖蛋白(ABCB1)、米托蒽醌耐药蛋白(ABCG2)和多药耐药蛋白1(ABCC1)功能的调节作用。
Mol Cell Biochem. 2007 Feb;296(1-2):85-95. doi: 10.1007/s11010-006-9302-8. Epub 2006 Sep 8.
7
Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux.耐药 MRP1 过度表达细胞通过 GSH 外排对黄酮类化合物和衍生物的旁敏感作用。
Biochem Pharmacol. 2014 Aug 1;90(3):235-45. doi: 10.1016/j.bcp.2014.05.017. Epub 2014 May 27.
8
Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells.沃鲁西利布,一种强效的细胞周期蛋白依赖性激酶4/6(CDK4/6)抑制剂,可拮抗ABCB1和ABCG2介导的癌细胞多药耐药性。
Cell Physiol Biochem. 2018;45(4):1515-1528. doi: 10.1159/000487578. Epub 2018 Feb 19.
9
MRP1 modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells.MRP1 调节剂与丁硫氨酸亚砜胺协同作用,利用旁系敏感性并选择性杀死表达 MRP1 的癌细胞。
Biochem Pharmacol. 2019 Oct;168:237-248. doi: 10.1016/j.bcp.2019.07.009. Epub 2019 Jul 11.
10
Human multidrug resistance protein 4 (MRP4) is a cellular efflux transporter for paracetamol glutathione and cysteine conjugates.人多药耐药蛋白 4(MRP4)是对乙酰氨基酚谷胱甘肽和半胱氨酸缀合物的细胞外排转运蛋白。
Arch Toxicol. 2020 Sep;94(9):3027-3032. doi: 10.1007/s00204-020-02793-4. Epub 2020 May 29.

引用本文的文献

1
Nanoparticle-Based Delivery Strategies for Combating Drug Resistance in Cancer Therapeutics.基于纳米颗粒的癌症治疗中抗耐药性递送策略
Cancers (Basel). 2025 Aug 11;17(16):2628. doi: 10.3390/cancers17162628.
2
Elevated BCRP Transporter and Altered NF-кB Pathway Mediate Zoledronic Acid Resistance in MCF-7 Cells.BCRP转运蛋白升高和NF-кB信号通路改变介导MCF-7细胞对唑来膦酸的耐药性。
J Biochem Mol Toxicol. 2025 Jul;39(7):e70397. doi: 10.1002/jbt.70397.
3
Metabolomic Characteristics of Aqueous Humor in Wet Age-Related Macular Degeneration and the Impact of Anti-VEGF Treatment.

本文引用的文献

1
Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells.缺氧影响多药耐药 K562 白血病细胞中的干细胞样特性。
Blood Cells Mol Dis. 2013 Oct;51(3):177-84. doi: 10.1016/j.bcmd.2013.05.003. Epub 2013 May 29.
2
Role of Nrf2 in cancer photodynamic therapy: regulation of human ABC transporter ABCG2.Nrf2 在癌症光动力治疗中的作用:调控人 ABC 转运体 ABCG2。
J Pharm Sci. 2013 Sep;102(9):3058-69. doi: 10.1002/jps.23563. Epub 2013 May 6.
3
NP-1250, an ABCG2 inhibitor, induces apoptotic cell death in mitoxantrone-resistant breast carcinoma MCF7 cells via a caspase-independent pathway.
湿性年龄相关性黄斑变性房水的代谢组学特征及抗血管内皮生长因子治疗的影响
Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):37. doi: 10.1167/iovs.66.2.37.
4
Cadmium transport by mammalian ATP-binding cassette transporters.金属镉通过哺乳动物 ATP 结合盒转运蛋白的转运。
Biometals. 2024 Jun;37(3):697-719. doi: 10.1007/s10534-024-00582-5. Epub 2024 Feb 6.
5
ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia.ABCC1 和谷胱甘肽代谢限制了 BCL-2 抑制剂在急性髓系白血病中的疗效。
Nat Commun. 2023 Sep 19;14(1):5709. doi: 10.1038/s41467-023-41229-2.
6
Brain Delivery of Nanomedicines: Trojan Horse Liposomes for Plasmid DNA Gene Therapy of the Brain.纳米药物的脑内递送:用于脑部质粒DNA基因治疗的特洛伊木马脂质体
Front Med Technol. 2020 Nov 16;2:602236. doi: 10.3389/fmedt.2020.602236. eCollection 2020.
7
ATP Binding Cassette Sub-family Member 2 (ABCG2) and Xenobiotic Exposure During Early Mouse Embryonic Stem Cell Differentiation.三磷酸腺苷结合盒亚家族成员 2(ABCG2)与早期胚胎干细胞分化中外源物质暴露
Birth Defects Res. 2018 Jan 15;110(1):35-47. doi: 10.1002/bdr2.1114. Epub 2017 Oct 9.
8
Leishmania LABCG1 and LABCG2 transporters are involved in virulence and oxidative stress: functional linkage with autophagy.利什曼原虫LABCG1和LABCG2转运蛋白与毒力和氧化应激有关:与自噬的功能联系
Parasit Vectors. 2017 May 30;10(1):267. doi: 10.1186/s13071-017-2198-1.
9
The LABCG2 Transporter from the Protozoan Parasite Leishmania Is Involved in Antimony Resistance.原生动物寄生虫利什曼原虫的LABCG2转运蛋白与锑抗性有关。
Antimicrob Agents Chemother. 2016 May 23;60(6):3489-96. doi: 10.1128/AAC.02813-15. Print 2016 Jun.
10
A role for ABCG2 beyond drug transport: Regulation of autophagy.ABCG2在药物转运之外的作用:自噬的调节。
Autophagy. 2016 May 3;12(5):737-51. doi: 10.1080/15548627.2016.1155009.
NP-1250,一种 ABCG2 抑制剂,通过一种 caspase 非依赖性途径诱导米托蒽醌耐药乳腺癌 MCF7 细胞发生凋亡性细胞死亡。
Oncol Rep. 2013 Apr;29(4):1492-500. doi: 10.3892/or.2013.2249. Epub 2013 Jan 24.
4
The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene?转录因子 NF-E2 相关因子 2 (Nrf2):原癌基因?
FASEB J. 2013 Feb;27(2):414-23. doi: 10.1096/fj.12-217257. Epub 2012 Oct 29.
5
Stimulus-induced expression of the ABCG2 multidrug transporter in HepG2 hepatocarcinoma model cells involves the ERK1/2 cascade and alternative promoters.刺激诱导的 HepG2 肝癌模型细胞中 ABCG2 多药转运蛋白的表达涉及 ERK1/2 级联和替代启动子。
Biochem Biophys Res Commun. 2012 Sep 21;426(2):172-6. doi: 10.1016/j.bbrc.2012.08.046. Epub 2012 Aug 16.
6
The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer.芳香酶抑制剂耐药性乳腺癌中肿瘤起始细胞群体中 HER2 信号的重要性。
Breast Cancer Res Treat. 2012 Oct;135(3):681-92. doi: 10.1007/s10549-012-2148-8. Epub 2012 Aug 10.
7
Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer.JNK1 信号通路的激活导致 ABCG2 介导的人结肠癌多药耐药。
PLoS One. 2012;7(8):e41763. doi: 10.1371/journal.pone.0041763. Epub 2012 Aug 1.
8
Mithramycin represses basal and cigarette smoke-induced expression of ABCG2 and inhibits stem cell signaling in lung and esophageal cancer cells.米托蒽醌抑制 ABCG2 的基础表达和香烟烟雾诱导的表达,并抑制肺癌和食管癌细胞中的干细胞信号通路。
Cancer Res. 2012 Aug 15;72(16):4178-92. doi: 10.1158/0008-5472.CAN-11-3983. Epub 2012 Jul 2.
9
β-catenin/Tcf-signaling appears to establish the murine ovarian surface epithelium (OSE) and remains active in selected postnatal OSE cells.β-连环蛋白/Tcf信号通路似乎参与了小鼠卵巢表面上皮(OSE)的形成,并在部分出生后的OSE细胞中保持活跃。
BMC Dev Biol. 2012 Jun 8;12:17. doi: 10.1186/1471-213X-12-17.
10
CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling.CXCR4 的激活通过 AhR 信号维持了他莫昔芬耐药乳腺癌细胞中的干细胞群体。
Br J Cancer. 2012 Jun 26;107(1):43-52. doi: 10.1038/bjc.2012.105. Epub 2012 May 29.